| 2021 | Design and Synthesis of TRAP1 Selective Inhibitors: H-Bonding with Asn171 Residue in TRAP1 Increases Paralog Selectivity | 강수성 | Article |
| 2016 | Effective killing of cancer cells and regression of tumor growth by K27 targeting sulfiredoxin | 이화정; 정우진 | Article |
| 2017 | Expediting the Design, Discovery and Development of Anticancer Drugs using Computational Approaches | 최선 | Review |
| 2023 | Machine learning-based prediction of risk factors for abnormal glycemic control in diabetic cancer patients receiving nutrition support: a case–control study | 곽혜선; 이정 | Article |
| 2015 | Nanoparticle-based combination therapy for cancer treatment | 이혁진 | Article |
| 2019 | Silver nanoparticles promote procoagulant activity of red blood cells: a potential risk of thrombosis in susceptible population | 임경민 | Article |
| 2018 | Submicromolar bisphenol A induces proliferation and DNA damage in human hepatocyte cell lines in vitro and in juvenile rats in vivo | 이윤실; 임경민; 김민정 | Article |
| 2016 | Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage | 이화정; 정우진; 창동신 | Article |
| 2015 | Synthesis and biological evaluation of 5-(fluoro-substituted-6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-alpha]pyridin-6-yl)imidazoles as inhibitors of transforming growth factor-beta type I receptor kinase | 신윤용; 김대기 | Article |
| 2020 | Ubiquitin-proteasome system (UPS) as a target for anticancer treatment | 송은주 | Review |
| 2023 | Ubiquitin–proteasome system as a target for anticancer treatment—an update | 송은주 | Review |
| 2020 | Who should be given priority for public funding? | 배그린 | Article |
